Importance of Pharmacologic Considerations in the Evaluation of New Treatments for Acute Spinal Cord Injury
- 1 January 1992
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Neurotrauma
- Vol. 9 (2), 173-176
- https://doi.org/10.1089/neu.1992.9.173
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The neuroprotective pharmacology of methylprednisoloneJournal of Neurosurgery, 1992
- Effect of Delayed Administration of U74006F (Tirilazad Mesylate) on Recovery of Locomotor Function After Experimental Spinal Cord InjuryJournal of Neurotrauma, 1991
- Correlation Between Attenuation of Posttraumatic Spinal Cord Ischemia and Preservation of Tissue Vitamin E by the 21-Aminosteroid U74006F: Evidence for anIn VivoAntioxidant MechanismJournal of Neurotrauma, 1989
- Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injuryJournal of Neurosurgery, 1988
- Glucocorticoid mechanisms in acute spinal cord injury: A review and therapeutic rationaleSurgical Neurology, 1982